Literature DB >> 2673796

Influence of nicardipine on renal function and plasma cyclosporin in renal transplant patients.

M Kessler1, P Netter, E Renoult, B Jonon, J M Mur, P Trechot, B Dousset.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2673796     DOI： 10.1007/bf00637751

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  Does nifedipine ameliorate cyclosporin A nephrotoxicity?

Authors:  J T Kwan; P J Foxall; J N Townend; M R Bending; A J Eisinger
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-03

2.  Does nifedipine ameliorate cyclosporin A nephrotoxicity?

Authors:  J Feehally; J Walls; N Mistry; T Horsburgh; J Taylor; P S Veitch; P R Bell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

3.  Verapamil inhibits cyclosporin metabolism.

Authors:  A Lindholm; S Henricsson
Journal:  Lancet       Date:  1987-05-30       Impact factor: 79.321

4.  Cyclosporin-diltiazem interaction.

Authors:  J M Pochet; Y Pirson
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

5.  Influence of diltiazem on cyclosporin clearance.

Authors:  J M Griño; I Sabate; A M Castelao; J Alsina
Journal:  Lancet       Date:  1986-06-14       Impact factor: 79.321

6.  Nicardipine increases cyclosporin blood levels.

Authors:  B Bourbigot; J Guiserix; J Airiau; L Bressollette; J F Morin; J Cledes
Journal:  Lancet       Date:  1986-06-21       Impact factor: 79.321

7.  Prevention of delayed graft function in cadaver kidney transplants by diltiazem.

Authors:  K Wagner; H H Neumayer
Journal:  Lancet       Date:  1985-12-14       Impact factor: 79.321

8.  Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethacin on cyclosporin A induced impairment of rat renal function.

Authors:  H Dieperink; P P Leyssac; H Starklint; K A Jørgensen; E Kemp
Journal:  Eur J Clin Invest       Date:  1986-12       Impact factor: 4.686

9.  Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil.

Authors:  K W Renton
Journal:  Biochem Pharmacol       Date:  1985-07-15       Impact factor: 5.858

10.  Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

Authors:  J J Curtis; R G Luke; E Dubovsky; A G Diethelm; J D Whelchel; P Jones
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321
  10 in total
  8 in total

Review 1.  Pharmacokinetic drug interactions with cyclosporin (Part II).

Authors:  G C Yee; T R McGuire
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications.

Authors:  Monique P Curran; Dean M Robinson; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Pharmacokinetic interactions with calcium channel antagonists (Part II).

Authors:  K D Schlanz; S A Myre; M B Bottorff
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

Review 4.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 5.  The clinical and economic potential of cyclosporin drug interactions.

Authors:  J E Martin; A J Daoud; T J Schroeder; M R First
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

Review 6.  The use of other drugs to allow a lower dosage of cyclosporin to be used. Therapeutic and pharmacoeconomic considerations.

Authors:  T E Jones
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

7.  The interaction of the diltiazem with oral and intravenous cyclosporine in rats.

Authors:  Sule Kalkan; Mukaddes Gumustekin; Oguz Aygoren; Yesim Tuncok; Ayse Gelal; Hulya Guven
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

8.  The interaction of the calcium channel blockers verapamil and nifedipine with cyclosporin A in pediatric renal transplant patients.

Authors:  J F Crocker; K W Renton; T L LeVatte; D H McLellan
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.